We Will End Als. Because of You.
Your support of ALS TDI has resulted in:
- The rigorous screening of over 400 potential treatments for ALS—more than any other ALS research lab in the world.
- The world's first Precision Medicine Program, a partnership with people with ALS, designed to speed up drug discovery and therapeutic development for ALS.
- ALS TDI becoming the first nonprofit biotech to develop a potential treatment for ALS, AT-1501, and bring it from our own lab, through FDA review and into a phase 1 clinical trial.
- The improvement of world-wide standards in preclinical drug screening in models of ALS.
Thanks to you we are closer to curing ALS, but our work is not done. Please continue to support
our mission to end ALS.